U.S. Site Closures As Takeda Restructures Vaccines Business
This article was originally published in The Pink Sheet Daily
Executive Summary
A fundamental restructuring of Takeda's vaccines operations will see the closure of three sites in the U.S. as it consolidates operations in this market in the Boston area as part of a revised global network for the unit.